|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
|
||
|
|
|
|
|
|
|
|
|
|
|
|
FORM
12b-25
|
||
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
NOTIFICATION
OF LATE FILING
|
||
|
(Check one):
|
☐
|
Form
10-K
|
☐
|
Form
20-F
|
☐
|
Form
11-K
|
☑
|
Form
10-Q
|
☐
|
Form
10-D
|
☐
|
Form
N-CEN
|
☐
|
Form
N-CSR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Period Ended: August 31,
2021
|
|||||||||||
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 10-K
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 20-F
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 11-K
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 10-Q
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
|
|
For the Transition Period
Ended:
|
|||||||||||
|
|
|
|||||||||||||
|
Nothing
in this form shall be construed to imply that the Commission has
verified any information contained herein.
|
|
If the notification
relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
|
|
|
|
|
|
PART
I — REGISTRANT INFORMATION
|
|
Healthcare
Business Resources Inc
|
|
|
Full Name of
Registrant
|
|
|
|
|
|
|
|
|
Former Name if
Applicable
|
|
|
|
|
|
718 Thompson Lane, Suite
108-273
|
|
|
Address of
Principal Executive Office (Street
and Number)
|
|
|
|
|
|
Nashville, TN 37204
|
|
|
City, State and Zip
Code
|
|
|
|
(a)
|
The reason
described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense
|
|
|
|
|
|
☑
|
(b)
|
The subject annual
report, semi-annual report, transition report on Form 10-K, Form
20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report or transition
report on Form 10-Q or subject distribution report on Form 10-D, or
portion thereof, will be filed on or before the fifth calendar day
following the prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
|
|
|
|
|
|
PART
IV — OTHER INFORMATION
|
|
(1)
|
Name and telephone
number of person to contact in regard to this
notification
|
||||||||
|
|
|||||||||
|
|
Stephen Epstein, CEO
|
|
(615)
|
|
856-5542
|
||||
|
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
||||
|
|
|||||||||
|
(2)
|
Have all other
periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify
report(s).
|
||||||||
|
Yes
|
☑
|
No
|
☐
|
|
|||||
|
|
|
||||||||
|
|
|||||||||
|
(3)
|
Is it anticipated
that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or
portion thereof?
|
||||||||
|
Yes
|
☐
|
No
|
☑
|
|
|||||
|
|
|||||||||
|
|
If so, attach an
explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
|
||||||||
|
|
|||||||||
|
|
|||||||||
|
|
Healthcare
Business Resources Inc.
|
|
||
|
(Name of Registrant
as Specified in Charter)
|
||||
|
|
||||
|
has caused this
notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
||||
|
|
||||
|
Date: October 18, 2021
|
|
|
By:
|
/s/ Stephen
Epstein
|
|
|
|
|
|
Stephen
Epstein
|
|
|
|
|
|
Chief Executive
Officer
|